5 research outputs found

    Dispositivo de lectura de microarrays de tipo eléctrico y reutilizable

    Get PDF
    Dispositivo de lectura de microarrays de tipo eléctrico y reutilizable. El objeto principal de la presente invención es un dispositivo de lectura eléctrica de microarrays que se puede limpiar y volver a utilizar más de una vez. El dispositivo (1, 1’, 1”) de lectura de microarrays (6) tiene las siguientes partes: una base (2, 2’, 2”), que tiene unos medios de apoyo (3, 3’, 3”) para situar la superficie de test (7) del microarray (6) en paralelo a una superficie de lectura (4) de la base (2, 2’, 2”); una matriz de transductores (5, 5’, 5”), dispuestos sobre la superficie de lectura (4) de la base (2, 2’, 2”), que traducen una variación de una magnitud eléctrica o química en una variación de una magnitud eléctrica; y unos medios de lectura (10), conectados a los transductores (5, 5’, 5”), que interpretan las señales eléctricas de los transductores (5, 5’, 5”).Peer reviewedConsejo Superior de Investigaciones Científicas (España)A1 Solicitud de patentes con informe sobre el estado de la técnic

    Impact of estrogen receptor alpha on the tamoxifen resistance in breast cancer patients

    Get PDF
    Genetic aberrations and changes in the activity of estrogen receptors alpha (ERa[lpha]) play an important role in the endocrine sensitivity. The aim of this study was to examine the relationship between the ESR1 expression level, its polymorphic variants, and the distribution pattern of ER[alpha] expression with the prognosis and efficacy of tamoxifen treatment in breast cancer patients. Our data suggest that the ESR1 expression level, SNPs in the ESR1 gene and the distribution pattern of ERα expression can be a potential molecular marker of tamoxifen resistance in breast cancer patients

    Dağlar çocuğu

    Get PDF
    C. C.'nin Talebe Defteri'nde tefrika edilen Dağlar Çocuğu adlı roman

    Acute mountain sickness.

    Get PDF
    Acute mountain sickness (AMS) is a clinical syndrome occurring in otherwise healthy normal individuals who ascend rapidly to high altitude. Symptoms develop over a period ofa few hours or days. The usual symptoms include headache, anorexia, nausea, vomiting, lethargy, unsteadiness of gait, undue dyspnoea on moderate exertion and interrupted sleep. AMS is unrelated to physical fitness, sex or age except that young children over two years of age are unduly susceptible. One of the striking features ofAMS is the wide variation in individual susceptibility which is to some extent consistent. Some subjects never experience symptoms at any altitude while others have repeated attacks on ascending to quite modest altitudes. Rapid ascent to altitudes of 2500 to 3000m will produce symptoms in some subjects while after ascent over 23 days to 5000m most subjects will be affected, some to a marked degree. In general, the more rapid the ascent, the higher the altitude reached and the greater the physical exertion involved, the more severe AMS will be. Ifthe subjects stay at the altitude reached there is a tendency for acclimatization to occur and symptoms to remit over 1-7 days
    corecore